Lapatinib Completed Phase 2 Trials for Neoplasms, Uterine Cervix / recurrent, IV-B Cervical cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00430781Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer